These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3713671)

  • 21. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations.
    Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices.
    Hashizume M; Yamaga H; Kitano S; Sugimachi K
    Hepatogastroenterology; 1990 Dec; 37(6):565-8. PubMed ID: 2289769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate.
    Miyoshi H; Ohshiba S; Matsumoto A; Takada K; Umegaki E; Hirata I
    Am J Gastroenterol; 1991 Nov; 86(11):1638-41. PubMed ID: 1951242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy.
    Hong SK; Lee HJ; Seo JK; Lee D; Hwang SW; Sung HS
    Dermatol Surg; 2010 Jul; 36(7):1148-52. PubMed ID: 20533938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
    Tsutsumi M; Takada A
    Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
    [No Abstract]   [Full Text] [Related]  

  • 26. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
    Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
    Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy.
    Tatemichi M; Nagata H; Sekizuka E; Morishita T; Miyairi M; Tsuchiya M; Ishii H
    Dig Dis Sci; 1996 Mar; 41(3):562-70. PubMed ID: 8617137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Extravascular lung water content following thoracic vagotomy. Experimental investigations in relation to the cause of pulmonary complications after surgery for esophageal cancer].
    Kanamaru H
    Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):119-31. PubMed ID: 6379410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Distribution of ethanolamine oleate after injection in esophageal varices].
    Sukigara M; Taguchi Y; Yamazaki T; Koga K; Miyamae T; Omoto R
    Nihon Geka Gakkai Zasshi; 1984 Dec; 85(12):1523-7. PubMed ID: 6527680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices.
    Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K
    Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Edema development and recovery in neurogenic pulmonary edema.
    Maron MB; Holcomb PH; Dawson CA; Rickaby DA; Clough AV; Linehan JH
    J Appl Physiol (1985); 1994 Sep; 77(3):1155-63. PubMed ID: 7836117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic and morphological changes in the dog kidney after injection of 5% ethanolamine oleate into the superior vena cava.
    Wada H; Hashizume M; Yamaga H; Kitano S; Sugimachi K
    Eur Surg Res; 1990; 22(2):63-70. PubMed ID: 2384125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental study on the effects of sclerosants for esophageal varices on blood coagulation, fibrinolysis and systemic hemodynamics.
    Suzuki N; Nakao A; Nonami T; Takagi H
    Gastroenterol Jpn; 1992 Jun; 27(3):309-16. PubMed ID: 1624075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The prophylactic effect of haptoglobin administration on renal disfunction in endoscopic injection sclerotherapy].
    Miyoshi H; Oshiba S; Matsumoto A; Hayashi K; Tei H
    Nihon Shokakibyo Gakkai Zasshi; 1989 Feb; 86(2):280. PubMed ID: 2754835
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices.
    Kang JH; Kambayashi J; Sakon M; Shiozaki H; Ogawa Y; Ohshiro T; Mori T
    Br J Surg; 1987 Jan; 74(1):50-3. PubMed ID: 3828735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethanolamine oleate in resistant idiopathic achalasia: a novel therapy.
    Niknam R; Mikaeli J; Mehrabi N; Mahmoudi L; Elahi E; Shirani S; Malekzadeh R
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1111-5. PubMed ID: 21971376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The destructive effects of sclerosant ethanolamine oleate on mammalian vessel endothelium.
    Masaki M; Obara K; Suzuki S; Orikasa K; Mitsuhashi H; Iwasaki K; Sakamoto H; Morito T; Kasukawa R
    Gastroenterol Jpn; 1990 Apr; 25(2):230-5. PubMed ID: 2347476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of angiotensin-converting enzyme by perindopril diacid in canine oleic acid pulmonary edema.
    Leeman M; Lejeune P; Naeije R
    Crit Care Med; 1987 Jun; 15(6):567-73. PubMed ID: 3032515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of embolizing agent (ethanolamine oleate; EO) on esophageal varices with special reference to endothelial injury].
    Masaki M; Mitsuhashi H; Kondo Y; Suzuki S; Wada T
    Nihon Shokakibyo Gakkai Zasshi; 1984 Jun; 81(6):1491. PubMed ID: 6471550
    [No Abstract]   [Full Text] [Related]  

  • 40. Splenic infarction: an unusual complication of ethanolamine oleate injection.
    Bar-Gil Shitrit A; Aharoni D; Zeides S; Braverman D
    Endoscopy; 2006 Apr; 38(4):432. PubMed ID: 16680654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.